The potential of BRAF-associated non-coding RNA as a therapeutic target in melanoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The potential of BRAF-associated non-coding RNA as a therapeutic target in melanoma
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 23, Issue 1, Pages 53-68
Publisher
Informa UK Limited
Online
2018-12-04
DOI
10.1080/14728222.2019.1554057
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development and validation of a plasma-based melanoma biomarker suitable for clinical use
- (2018) Ryan Van Laar et al. BRITISH JOURNAL OF CANCER
- Loss of miR-204 expression is a key event in melanoma
- (2018) Marco Galasso et al. Molecular Cancer
- miR-21 depletion in macrophages promotes tumoricidal polarization and enhances PD-1 immunotherapy
- (2018) Jiajia Xi et al. ONCOGENE
- AXL/AKT axis mediated-resistance to BRAF inhibitor depends on PTEN status in melanoma
- (2018) Qiang Zuo et al. ONCOGENE
- Microenvironment-Driven Dynamic Heterogeneity and Phenotypic Plasticity as a Mechanism of Melanoma Therapy Resistance
- (2018) Farzana Ahmed et al. Frontiers in Oncology
- Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma
- (2018) Luigi Fattore et al. CELL DEATH AND DIFFERENTIATION
- Codon-specific translation reprogramming promotes resistance to targeted therapy
- (2018) Francesca Rapino et al. NATURE
- Noncoding RNAs and immune checkpoints-clinical implications as cancer therapeutics
- (2017) Maria A. Smolle et al. FEBS Journal
- Function and Clinical Implications of Long Non-Coding RNAs in Melanoma
- (2017) Georg Richtig et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- BANCR contributes to the growth and invasion of melanoma by functioning as a competing endogenous RNA to upregulate Notch2 expression by sponging miR-204
- (2017) Bingjie Cai et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- HOTAIR role in melanoma progression and its identification in the blood of patients with advanced disease
- (2017) Monica Cantile et al. JOURNAL OF CELLULAR PHYSIOLOGY
- An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition
- (2017) Helen L. Young et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Checkpoint inhibitors in melanoma and early phase development in solid tumors: what’s the future?
- (2017) Paolo A. Ascierto et al. Journal of Translational Medicine
- Genome-scale activation screen identifies a lncRNA locus regulating a gene neighbourhood
- (2017) Julia Joung et al. NATURE
- Targeted agents and immunotherapies: optimizing outcomes in melanoma
- (2017) Jason J. Luke et al. Nature Reviews Clinical Oncology
- BRAFV600inhibition alters the microRNA cargo in the vesicular secretome of malignant melanoma cells
- (2017) Taral R. Lunavat et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Selective targeting of point-mutated KRAS through artificial microRNAs
- (2017) Mario Acunzo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of plasma microRNAs as new potential biomarkers with high diagnostic power in human cutaneous melanoma
- (2017) Stefano Fogli et al. TUMOR BIOLOGY
- Key Roles of AXL and MER Receptor Tyrosine Kinases in Resistance to Multiple Anticancer Therapies
- (2017) Marie Schoumacher et al. Current Oncology Reports
- Overcoming resistance to targeted therapy with immunotherapy and combination therapy for metastatic melanoma
- (2017) Hilary R. Keller et al. Oncotarget
- PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p
- (2017) Valentina Audrito et al. Oncotarget
- Long non-coding RNAs in cutaneous melanoma: clinical perspectives
- (2017) Eva Hulstaert et al. Oncotarget
- MicroRNAs in melanoma development and resistance to target therapy
- (2017) Luigi Fattore et al. Oncotarget
- Context-dependent miR-204 and miR-211 affect the biological properties of amelanotic and melanotic melanoma cells
- (2017) Marianna Vitiello et al. Oncotarget
- Upregulation of MicroRNA-1246 Is Associated with BRAF Inhibitor Resistance in Melanoma Cells with Mutant BRAF
- (2017) Jae-Hyeon Kim et al. Cancer Research and Treatment
- ANRIL lncRNA triggers efficient therapeutic efficacy by reprogramming the aberrant INK4-hub in melanoma
- (2016) Shiqiong Xu et al. CANCER LETTERS
- Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors
- (2016) Gao Zhang et al. JOURNAL OF CLINICAL INVESTIGATION
- Melanoma addiction to the long non-coding RNA SAMMSON
- (2016) Eleonora Leucci et al. NATURE
- Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma
- (2016) Mansi A. Parasramka et al. PHARMACOLOGY & THERAPEUTICS
- The emerging role of long non-coding RNAs in cutaneous melanoma
- (2016) Eleonora Leucci et al. Pigment Cell & Melanoma Research
- miR-579-3p controls melanoma progression and resistance to target therapy
- (2016) Luigi Fattore et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma
- (2016) Lucas Goedert et al. Oncotarget
- miR-7 reverses the resistance to BRAFi in melanoma by targeting EGFR/IGF-1R/CRAF and inhibiting the MAPK and PI3K/AKT signaling pathways
- (2016) Xiaoyan Sun et al. Oncotarget
- Long non-coding RNA MALAT1 acts as a competing endogenous RNA to promote malignant melanoma growth and metastasis by sponging miR-22
- (2016) Wenkang Luan et al. Oncotarget
- miR-28 modulates exhaustive differentiation of T cells through silencing programmed cell death-1 and regulating cytokine secretion
- (2016) Qing Li et al. Oncotarget
- Clinical significance of long noncoding RNA SPRY4-IT1 in melanoma patients
- (2016) Teng Liu et al. FEBS Open Bio
- Long Intergenic Noncoding RNA 00511 Acts as an Oncogene in Non–small-cell Lung Cancer by Binding to EZH2 and Suppressing p57
- (2016) Cheng-Cao Sun et al. Molecular Therapy-Nucleic Acids
- Tunable-Combinatorial Mechanisms of Acquired Resistance Limit the Efficacy of BRAF/MEK Cotargeting but Result in Melanoma Drug Addiction
- (2015) Gatien Moriceau et al. CANCER CELL
- Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance
- (2015) Willy Hugo et al. CELL
- Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms
- (2015) Douglas B. Johnson et al. EUROPEAN JOURNAL OF CANCER
- Serum long non-coding RNA, snoRNA host gene 5 level as a new tumor marker of malignant melanoma
- (2015) Yuki Ichigozaki et al. EXPERIMENTAL DERMATOLOGY
- MicroRNA expression in BRAF-mutated and wild-type metastatic melanoma and its correlation with response duration to BRAF inhibitors
- (2015) Rosamaria Pinto et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
- (2015) Dirk Schadendorf et al. JOURNAL OF CLINICAL ONCOLOGY
- The CASC15 Long Intergenic Noncoding RNA Locus Is Involved in Melanoma Progression and Phenotype Switching
- (2015) Laurent Lessard et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
- (2015) Antoni Ribas et al. LANCET ONCOLOGY
- Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial
- (2015) Jean Jacques Grob et al. LANCET ONCOLOGY
- Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Toward predicting metastatic progression of melanoma based on gene expression data
- (2015) Yuanyuan Li et al. Pigment Cell & Melanoma Research
- miR-200c/Bmi1 axis and epithelial-mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment
- (2015) Shujing Liu et al. Pigment Cell & Melanoma Research
- The Landscape of long noncoding RNA classification
- (2015) Georges St. Laurent et al. TRENDS IN GENETICS
- The plasma lncRNA acting as fingerprint in non-small-cell lung cancer
- (2015) Xiaodong Hu et al. TUMOR BIOLOGY
- Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma
- (2015) Luigi Fattore et al. Oncotarget
- Comparison of a healthy miRNome with melanoma patient miRNomes: are microRNAs suitable serum biomarkers for cancer?
- (2015) Christiane Margue et al. Oncotarget
- Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b
- (2015) Elisabetta Vergani et al. Oncotarget
- The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis
- (2015) Mitchell S. Stark et al. EBioMedicine
- MiR-21 Enhances Melanoma Invasiveness via Inhibition of Tissue Inhibitor of Metalloproteinases 3 Expression: In Vivo Effects of MiR-21 Inhibitor
- (2015) Sara E. Martin del Campo et al. PLoS One
- miR-524-5p suppresses the growth of oncogenic BRAF melanoma by targeting BRAF and ERK2
- (2015) Szu-Mam Liu et al. Oncotarget
- microRNA-340 as a modulator of RAS–RAF–MAPK signaling in melanoma
- (2014) Ashley M. Poenitzsch Strong et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Study of Circulating MicroRNA-125b Levels in Serum Exosomes in Advanced Melanoma
- (2014) Estibaliz Alegre et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients
- (2014) Nathaniel H. Fleming et al. CANCER
- MicroRNA-155 deficiency enhances the recruitment and functions of myeloid-derived suppressor cells in tumor microenvironment and promotes solid tumor growth
- (2014) Junfeng Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
- (2014) Suzanne L. Topalian et al. JOURNAL OF CLINICAL ONCOLOGY
- Regulation of microRNA biogenesis
- (2014) Minju Ha et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma
- (2014) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- In Vivo Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple Myeloma
- (2014) Maria Teresa Di Martino et al. PLoS One
- Long Non-Coding RNA BANCR Promotes Proliferation in Malignant Melanoma by Regulating MAPK Pathway Activation
- (2014) Ruiya Li et al. PLoS One
- MicroRNAs in cancer: biomarkers, functions and therapy
- (2014) Josie Hayes et al. TRENDS IN MOLECULAR MEDICINE
- Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
- (2014) Limo Chen et al. Nature Communications
- The Non-Coding RNA Llme23 Drives the Malignant Property of Human Melanoma Cells
- (2013) Chuan-Fang Wu et al. Journal of Genetics and Genomics
- Activation of an early feedback survival loop involving phospho-ErbB3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-ErbB3 antibodies
- (2013) Luigi Fattore et al. Journal of Translational Medicine
- On the classification of long non-coding RNAs
- (2013) Lina Ma et al. RNA Biology
- Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy
- (2013) H. Shi et al. Cancer Discovery
- Long Noncoding RNA HOTAIR Is Associated with Motility, Invasion, and Metastatic Potential of Metastatic Melanoma
- (2013) Lihua Tang et al. Biomed Research International
- The Noncoding RNA MALAT1 Is a Critical Regulator of the Metastasis Phenotype of Lung Cancer Cells
- (2012) T. Gutschner et al. CANCER RESEARCH
- BRAFV600Eremodels the melanocyte transcriptome and inducesBANCRto regulate melanoma cell migration
- (2012) Ross J. Flockhart et al. GENOME RESEARCH
- Serum microRNAs as biomarkers for recurrence in melanoma
- (2012) Erica B Friedman et al. Journal of Translational Medicine
- The role of BRAF V600 mutation in melanoma
- (2012) Paolo A Ascierto et al. Journal of Translational Medicine
- Oncogenic B-Raf signaling in melanoma cells controls a network of microRNAs with combinatorial functions
- (2012) K L Couts et al. ONCOGENE
- Non-coding RNA and antisense RNA. Nature’s trash or treasure?
- (2011) Stuart Knowling et al. BIOCHIMIE
- Tumor Suppressive MicroRNAs miR-34a/c Control Cancer Cell Expression of ULBP2, a Stress-Induced Ligand of the Natural Killer Cell Receptor NKG2D
- (2011) A. Heinemann et al. CANCER RESEARCH
- MicroRNA signatures differentiate melanoma subtypes
- (2011) Elcie Chan et al. CELL CYCLE
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response
- (2010) Maite Huarte et al. CELL
- MicroRNA Expression Profiles Associated with Mutational Status and Survival in Malignant Melanoma
- (2010) Stefano Caramuta et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficient in vivo microRNA targeting of liver metastasis
- (2010) C Huynh et al. ONCOGENE
- Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15 INK4B tumor suppressor gene
- (2010) Y Kotake et al. ONCOGENE
- Novel Primate-Specific Genes, RMEL 1, 2 and 3, with Highly Restricted Expression in Melanoma, Assessed by New Data Mining Tool
- (2010) Josane F. Sousa et al. PLoS One
- miRNA Expression Profiling in Melanocytes and Melanoma Cell Lines Reveals miRNAs Associated with Formation and Progression of Malignant Melanoma
- (2009) Daniel W. Mueller et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals
- (2009) Mitchell Guttman et al. NATURE
- Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression
- (2009) Ahmad M. Khalil et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials
- (2008) Edward L. Korn et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now